Immutable evidence record · ticker

NervGen Pharma Corp. (NGEN)

Published as observed on 19 August 2026 at 10:15 BST.

NervGen Pharma Corp. has a balanced company news read. Its latest completed weekly trend is negative.

As of
19 Aug 2026, 10:15
Scope
company and instrument
Evidence
6 items
Independent sources
2
Country
United States
Sector
Healthcare
Previous read
50.000
Change

Verification

Evidence & related research

This is dated market research. Coverage may be delayed, incomplete or unavailable.

Cite this record:
Sharemaestro, NervGen Pharma Corp. (NGEN), 2026-08-19, https://sharemaestro.com/evidence/38bd0959-fe08-43ee-9ae4-a6269c6f1e93/
Record checksum 0255131646ba3e8de61c0be4539baa71aec6e00ef56e2b67bacba909c444aca1

Evidence context